Regulatory Status & Safety
ATP was marketed as a dietary ingredient in the United States prior to October 15, 1994 (the date the Dietary Supplement Health and Education Act, or DSHEA, was enacted) and therefore does not require FDA premarket notification.
PEAK ATP® has a tremendous safety profile. It is not a stimulant, and therefore does not adversely affect heart rate or raise blood pressure. In the multiple human clinical trials and pilot studies conducted on PEAK ATP® to date, no adverse reactions have been observed.
We always recommend consulting with a medical professional for guidance before changing or undertaking a new diet or exercise program or adding a dietary supplement to your diet. Advance consultation with your physician is particularly important if you are under eighteen (18) years old, pregnant, nursing, or have health problems.
In 2015 PEAK ATP was granted self-affirmed GRAS (Generally Recognized As Safe) status for use in functional food, bars and powders. A leading independent panel of scientific experts made the decision after reviewing comprehensive scientific evidence covering the oral use of PEAK ATP®. This accreditation compliments our comprehensive technical dossier that includes strong efficacy and safety data, non-GMO, Kosher and cGMP manufacturing accreditations.